The Organizing Committee invites you to submit an abstract of your scientific research to be considered for an oral or poster presentation at the Second Annual Symposium on the Functional Genomics of Critical Illness and Injury, November 17- 18, 2003. The deadline for submission is Friday, October 17, 2003. Notice of acceptance will be sent by Friday, October 31, 2003. An abstract booklet will be prepared and handed out to all attendees.

PLEASE NOTE: Conference registration is required for everyone submitting abstracts (see registration page).

All abstracts are to be submitted electronically through the following On-Line Abstract Submission form.

Abstract Title: An abstract must have a short, specific title that indicates the nature of the investigation.

Contact/Presenter name: Include information for the presenting author, who should receive all correspondence concerning this abstract. All submissions should include mailing address, telephone, and e-mail address.

Author(s): List all authors of the abstract. For each author supply the first initial and last name.

Affiliation(s): List all affiliations with city, state, and country.

Key words: Provide three key words that best describe the topic or topics addressed in the abstract.

Abstract text: Upload the body of your text. Abstracts must be submitted in Microsoft Word. The abstract should have four clearly identifiable components: Background, Methods, Results, and Conclusion. You may use special Greek or mathematical characters in your abstract as well as charts and images. Text, charts, and images of your abstract must fit within a 3 inch by 5 inch block. Text must not exceed 250 words (excluding title and author(s)). The abstract must be submitted in Times New Roman font, 12 pitch and single-spaced.

Source of funding: List primary and secondary sources.

Financial Disclosure: Authors of scientific oral or poster presentations who have entered into a financial relationship with sponsoring companies or organizations about whose product or services they are reporting must include a disclosure statement at the end of their abstracts, e.g., “Research supported by ACME Pharmaceuticals.” It is recognized that much scientific research is supported by organizations that have a commercial interest in the results of the research. The disclosure policy is not intended to discourage such support or restrict the dissemination of the research, but rather to permit members of the audience to form their own judgments about the research with the full disclosure of the facts.

Return to Top